Adam Maeder

Adam Maeder is a director and senior research analyst focused on the medical technology sector. Prior to joining Piper Sandler in 2019, Maeder worked in medical technology equity research at Wells Fargo Securities. Additionally, he worked at Westwicke Partners providing investor relations strategy and capital markets advisory to medical technology and diagnostics companies. Maeder began his career working on the equity capital markets desk at Piper Sandler. Maeder holds a BBA in finance from the University of Iowa.

Universe Coverage

Medical Technology and Devices
AXNX	Axonics Modulation Technologies, Inc.
LIVN	LivaNova
APEN	Apollo Endosurgery, Inc.
EW	Edwards Lifesciences Corporation
SILK	Silk Road Medical, Inc.
SWAV	Shockwave Medical, Inc.
ISRG	Intuitive Surgical, Inc.
INSP	Inspire Medical Systems, Inc.
NVRO	Nevro Corp.
STXS	Stereotaxis, Inc.
NYXH	Nyxoah SA
RBOT	Vicarious Surgical, Inc.
NARI	Inari Medical, Inc.
STIM	Neuronetics, Inc.
TCMD	Tactile Systems Technology, Inc.
NSPR	InspireMD, Inc.